Cargando…

Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted

Detalles Bibliográficos
Autores principales: Roberts, Darren M, Roberts, Jason A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206394/
https://www.ncbi.nlm.nih.gov/pubmed/17488492
http://dx.doi.org/10.1186/cc5786
_version_ 1782148461502660608
author Roberts, Darren M
Roberts, Jason A
author_facet Roberts, Darren M
Roberts, Jason A
author_sort Roberts, Darren M
collection PubMed
description
format Text
id pubmed-2206394
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22063942008-01-19 Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted Roberts, Darren M Roberts, Jason A Crit Care Letter BioMed Central 2007 2007-05-02 /pmc/articles/PMC2206394/ /pubmed/17488492 http://dx.doi.org/10.1186/cc5786 Text en Copyright © 2007 BioMed Central Ltd
spellingShingle Letter
Roberts, Darren M
Roberts, Jason A
Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted
title Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted
title_full Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted
title_fullStr Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted
title_full_unstemmed Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted
title_short Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted
title_sort conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206394/
https://www.ncbi.nlm.nih.gov/pubmed/17488492
http://dx.doi.org/10.1186/cc5786
work_keys_str_mv AT robertsdarrenm conclusionsregardingtheefficacyoftreatmentsforneurolepticmalignantsyndromeshouldbetemperedgivenpoorqualitydataregardlessoftheanalysisconducted
AT robertsjasona conclusionsregardingtheefficacyoftreatmentsforneurolepticmalignantsyndromeshouldbetemperedgivenpoorqualitydataregardlessoftheanalysisconducted